We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Advice on Use of Novel Drug Development Tools in Submissions
EMA Updates Advice on Use of Novel Drug Development Tools in Submissions
The European Medicines Agency is encouraging drugmakers looking to apply novel drug development tools to first seek the agency’s blessing and get qualification or prospective advice.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor